Robot-assisted versus conventional minimally invasive oesophagectomy for oesophageal squamous cell carcinoma (RAMIE): a multicentre, open-label, randomised, phase 3, non-inferiority trial - PubMed
19 hours ago
- #robot-assisted surgery
- #oesophageal cancer
- #clinical trial
- The RAMIE trial is a phase 3, non-inferiority study comparing robot-assisted and thoracoscopic oesophagectomy for oesophageal squamous cell carcinoma.
- It involved 362 patients in China, randomized into two groups, with a median follow-up of 71.5 months.
- 5-year overall survival was 69.4% with robot-assisted surgery versus 56.2% with thoracoscopic surgery, confirming non-inferiority and suggesting superiority.
- Complication rates and conversions to open surgery were similar between the two groups, with one treatment-related death in each.